New York – It’s always good to see cancer researchers receive a Nobel prize.
I don’t think anyone at #CICON18 was surprised to see Dr Jim Allison as a recipient. I’m delighted to see Prof Honjo was also recognised too, as he discovered the PD-1 checkpoint target:
The 2018 #NobelPrize in Physiology or Medicine has been awarded jointly to James P. Allison and Tasuku Honjo “for their discovery of cancer therapy by inhibition of negative immune regulation.” pic.twitter.com/gk69W1ZLNI
— The Nobel Prize (@NobelPrize) October 1, 2018
Moving on it’s time for some highlights of the first day of the meeting – a couple of interesting findings emerged from the proceedings…